Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.

Literature DB >> 2069842

AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.

R Gray, R James, J Mossman, S Stenning.

Abstract

Entities: Disease

Mesh：

Year: 1991 PMID： 2069842 PMCID： PMC1972556 DOI： 10.1038/bjc.1991.187

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

7 in total

1. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I).

Authors: J C Wereldsma; E D Bruggink; W S Meijer; J A Roukema; W L van Putten
Journal: Cancer Date: 1990-02-01 Impact factor: 6.860

2. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.

Authors: U Metzger; B Mermillod; P Aeberhard; F Gloor; A Bissat; R Egeli; U Laffer; S Martinoli; W Mueller; R Schroeder
Journal: World J Surg Date: 1987-08 Impact factor: 3.352

3. Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.

Authors: N Wolmark; H Rockette; D L Wickerham; B Fisher; C Redmond; E R Fisher; M Potvin; R J Davies; J Jones; A Robidoux
Journal: J Clin Oncol Date: 1990-09 Impact factor: 44.544

Review 4. Adjuvant therapy of colorectal cancer. Why we still don't know.

Authors: M Buyse; A Zeleniuch-Jacquotte; T C Chalmers
Journal: JAMA Date: 1988-06-24 Impact factor: 56.272

5. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.

Authors: T R Buroker; C G Moertel; T R Fleming; L K Everson; S A Cullinan; J E Krook; J A Mailliard; R F Marschke; D J Klaassen; J A Laurie
Journal: J Clin Oncol Date: 1985-12 Impact factor: 44.544

6. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

Authors: C G Moertel; T R Fleming; J S Macdonald; D G Haller; J A Laurie; P J Goodman; J S Ungerleider; W A Emerson; D C Tormey; J H Glick
Journal: N Engl J Med Date: 1990-02-08 Impact factor: 91.245

7. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.

Authors: I Taylor; D Machin; M Mullee; G Trotter; T Cooke; C West
Journal: Br J Surg Date: 1985-05 Impact factor: 6.939

7 in total

8 in total

1. Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.

Authors: M K Parmar; L A Stewart; D G Altman
Journal: Br J Cancer Date: 1996-08 Impact factor: 7.640

2. Outcome in colorectal adenocarcinoma: two seven-year studies of a population.

Authors: N L Gordon; A A Dawson; B Bennett; G Innes; O Eremin; P F Jones
Journal: BMJ Date: 1993-09-18

3. Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study.

Authors: W Graf; J E Westlin; L Påhlman; B Glimelius
Journal: Int J Colorectal Dis Date: 1994-04 Impact factor: 2.571

8. The Covariance Adjustment Approaches for Combining Incomparable Cox Regressions Caused by Unbalanced Covariates Adjustment: A Multivariate Meta-Analysis Study.

Authors: Tania Dehesh; Najaf Zare; Seyyed Mohammad Taghi Ayatollahi
Journal: Comput Math Methods Med Date: 2015-09-01 Impact factor: 2.238